Home › COPD › Massachusetts › Boston
COPD clinical trials in Boston, MA
17 studies for COPD are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RecruitingPhase 3
- Research Site, Boston
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
Recruiting
- VA Boston, Boston
- BIDMC, Boston
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RecruitingPhase 2
- Brigham and Women's Hospital, Boston
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- Brigham & Women's Hospital- Site Number : 8400148, Boston
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
RecruitingPhase 4
- Brigham & Women's Hospital- Site Number : 8400014, Boston
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Recruiting
- Beth Israel Deaconess Medical Center, Boston
Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction
Recruiting
- Beth Israel Deaconess Medical Center, Boston
STRIVE Post-Market Registry Study
RecruitingObservational study
- Beth Israel Decaconess, Boston
Multi-Center Clean Air Randomized Controlled Trial in COPD
RecruitingPhase 3
- Beth Israel Deaconess Medical Center, Boston
A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
Recruiting
- Beth Israel Deaconess Medical Center, Boston
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
RecruitingPhase 2
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Recruiting
- Beth Israel Deaconess Medical Center, Boston
Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema
Recruiting
- Beth Israel Deaconess Medical Center, Boston
Home Hospital for Suddenly Ill Adults
Recruiting
- Brigham and Women's Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
Recruiting
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
RecruitingObservational study
- Brigham and Women's Hospital, Boston
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Recruiting
- Tufts Medical Center, Boston
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA23 studies
- Miami, FL18 studies
- Birmingham, AL17 studies
- Orlando, FL15 studies
- Houston, TX15 studies
- Baltimore, MD14 studies
- Chicago, IL14 studies
- Dallas, TX12 studies
- Pittsburgh, PA12 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
- Los Angeles, CA9 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.